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The 5S ribonucleoprotein particle (RNP) complex,
consisting of RPL11, RPL5, and 5S rRNA, is
implicated in p53 regulation under ribotoxic stress.
Here, we show that the 5S RNP contributes to p53
activation and promotes cellular senescence in
response to oncogenic or replicative stress. Onco-
genic stress accelerates rRNA transcription and
replicative stress delays rRNA processing, resulting
in RPL11 and RPL5 accumulation in the ribosome-
free fraction, where they bind MDM2. Experimental
upregulation of rRNA transcription or downregula-
tion of rRNA processing, mimicking the nucleolus
under oncogenic or replicative stress, respectively,
also induces RPL11-mediated p53 activation and
cellular senescence. We demonstrate that exoge-
nous expression of certain rRNA-processing factors
rescues the processing defect, attenuates p53 accu-
mulation, and increases replicative lifespan. To sum-
marize, the nucleolar-5S RNP-p53 pathway functions
as a senescence inducer in response to oncogenic
and replicative stresses.
INTRODUCTION
Most mammalian somatic cells lose proliferative capacity as a
consequence of a finite number of population doublings, activa-
tion of oncogenes, inactivation of tumor suppressor genes, or
treatment with DNA damage-inducing drugs, a state termed
cellular senescence (Campisi and d’Adda di Fagagna, 2007;
Kuilman et al., 2010; Pe´rez-Mancera et al., 2014). Although
cellular senescence acts as a barrier to tumor formation by pre-
venting proliferation or by inducing immune clearance of pre-ma-
lignant cells, recent studies have revealed that senescent cells
are associated with age-related dysfunction through the inflam-
matory response (Baker et al., 2011; Campisi and d’Adda di Fa-
gagna, 2007; Kang et al., 2011; Xue et al., 2007).1310 Cell Reports 10, 1310–1323, March 3, 2015 ª2015 The AuthorsSeveral cellular events, including telomere dysfunction, DNA
damage response (DDR), and oxidative stress response, acti-
vate p53-p14/p19Arf and p16INK4A-RB pathways during senes-
cence (Campisi and d’Adda di Fagagna, 2007; Cichowski and
Hahn, 2008; de Lange, 2009; Kuilman et al., 2010; Parrinello
et al., 2003; Schramek et al., 2011). The tumor suppressor p53
acts as a vital regulator of stress response by inducing distinct
classes of target genes for cell-cycle arrest, apoptosis, DNA
repair, or cellular senescence (Levine and Oren, 2009; Prives
and Hall, 1999; Vousden and Lane, 2007). Under normal physio-
logical conditions, p53 is maintained at low levels by its interac-
tion with E3 ubiquitin ligases such as MDM2 (Kruse and Gu,
2009; Lee and Gu, 2010). MDM2 is inhibited in response to cell
stress, followed by upregulation of p53 transcriptional activity
and the production of a number of downstream effects (Kruse
and Gu, 2009; Lee and Gu, 2010; Levine and Oren, 2009;
Prives and Hall, 1999; Vousden and Lane, 2007). For example,
Arf binds and inhibits MDM2, thus preventing the degradation
of p53 during replicative senescence and oncogene-induced
senescence (Kamijo et al., 1998; Pomerantz et al., 1998; Randle
et al., 2001; Zhang and Xiong, 1999).
Recent studies have revealed that the nucleolus senses
various stressors and plays a coordinating role in p53 activation
(Boulon et al., 2010; Rubbi and Milner, 2003). The most well-
known function of the nucleolus is ribosome biogenesis, which
involves transcription of precursor ribosomal RNA (pre-rRNA),
pre-rRNA processing, and assembly of mature rRNA with ribo-
somal proteins. The nucleolus comprises RNA and a large
number of proteins, some of which are released during stress
(Andersen et al., 2005). For example, nucleophosmin, nucleolin,
nucleostemin, and the ribosomal protein L11 (RPL11), RPL5,
RPL23, and RPS7 directly bind to MDM2 and prevent ubiqui-
tin-mediated p53 degradation, which delays proliferation under
nucleolar stress (Dai and Lu, 2004; Manfredi, 2010; Marechal
et al., 1994). RPL11 is awell-studied participant in the p53-nucle-
olar stress response pathway (Bhat et al., 2004; Lohrum et al.,
2003; Macias et al., 2010; Zhang et al., 2003). Translational upre-
gulation of RPL11 is observed during impaired 40S ribosome
biogenesis, resulting in p53 activation (Fumagalli et al., 2009,
2012). Several studies have revealed that RPL11 regulates
MDM2 as part of a 5S ribonucleoprotein particle (RNP) consist-
ing of RPL11, RPL5, and 5S rRNA (Donati et al., 2013; Li and Gu,
2011; Sloan et al., 2013a). Nucleolar proteins, including RRS1,
BXDC1, and PICT, are implicated in 5S RNP production. Impor-
tantly, Arf and 5S RNP components, particularly RPL11, interact
with each other in Arf-overexpressing cells (Dai et al., 2012;
Sloan et al., 2013a). Overexpression of Arf enhances the
RPL11-MDM2 interaction, leading to p53 activation (Dai et al.,
2012; Sloan et al., 2013a). However, the relevance of 5S RNP
to cellular senescence remains unknown.
In this study, we show that 5S RNP components are involved
in p53 activation and cellular senescence under oncogenic and
replicative stresses. Oncogenic stress accelerated rRNA tran-
scription, whereas replicative stress delayed rRNA processing,
both of which triggered p53 activation and cellular senescence.
Indeed, we extended the replicative lifespan of mouse embry-
onic fibroblasts (MEFs) by exogenously expressing rRNA-
processing factors. Moreover, accelerated rRNA transcription
by overexpressing transcription initiation factor IA (TIF-IA) or
delayed rRNA processing by depleting rRNA-processing factors
induced RPL11-mediated p53 activation and cellular senes-
cence, indicating that 5S RNP couple a perturbed ribosomal
biogenesis with p53 activation during senescence.
RESULTS
Oncogenic and Replicative Stresses Increase Nucleolar
Size by Accelerating rRNA Transcription or Inhibiting
rRNA Processing
Aberrant activation of oncogenes or persistent replicative stress
induces cellular senescence, accompanied by high expression
levels of p53, p21, and p16 (Kuilman et al., 2010; Serrano
et al., 1997). Senescent cells also display drastic changes
in morphology, such as enlarged and flattened shapes and
enlarged nucleoli (Guarente, 1997; Kuilman et al., 2010; Serrano
et al., 1997). Consistent with these observations, the transduc-
tion of oncogenic HRasG12V or E2F1 increased p53, p21, and
p16 protein levels in primary MEFs and MCF-7 human breast
cancer cells (Figures 1A and S1A). Consequent replicative stress
at a population doubling level (PDL) of 14 increased p53, p21,
and p16 protein levels (Figure 1A). Next, we evaluated induction
of cellular senescence in HRasG12V- or E2F1-expressing cells
and PDL14-MEFs by microscopy and senescence-associated
b-galactosidase (SA-b-gal) staining, a widely used marker of
cellular senescence (Dimri et al., 1995; Kuilman et al., 2010).
These cells displayed a marked increase in SA-b-gal activity,
flattened morphology, and enlarged nucleoli, suggesting that
these stresses induced cellular senescence (Figures 1B, 1C,
S1B, and S1C). Immunofluorescence staining using upstream
binding factor (UBF) and Myb-binding protein 1A (MYBBP1A)
as nucleolar markers revealed that cells treated with control
(Ctrl) vector or PDL4-MEFs had multiple nucleoli, whereas onco-
genic HRasG12V- or E2F1-expressing cells and PDL14-MEFs
had a large merged nucleolus (Figures 1C and S1C). This result
suggests that senescence-inducing stresses affect ribosome
biogenesis in the nucleolus. Thus, we examined rRNA produc-
tion by northern blotting using probes specific for the internal
transcribed spacer (ITS1) region (Figure S1D). Increases in 47/Ce45S, 41S, 30S, and 21S pre-rRNA species were observed in
oncogenic HRasG12V- or E2F1-expressing cells and PDL14-
MEFs (Figures 1D and S1E). To further investigate the quantity
of RNA species within the nucleolus, we isolated nucleoli and
determined nucleolar RNA content. Nucleolar RNA content in
MEFs and MCF-7 cells increased following exposure to onco-
genic and replicative stresses (Figures 1E and S1F). Next, we
examined rRNA transcription and processing under these stress
conditions using nuclear run-on assays and a pulse-chase label-
ing experiment. The nuclear run-on assays indicated that onco-
genic HRasG12V or E2F1 accelerated rRNA transcription (Figures
1F and S1G), whereas replicative stress did not (Figure 1G). To
investigate the cause of replicative-stress-induced increase in
nucleolar RNA content, we examined the expression of rRNA-
processing genes. Oncogenic stress scarcely affected expres-
sion of the rRNA-processing genes: dyskeratosis congenita 1
(Dkc1), ribosomal RNA processing 5 (Rrp5), Rrs1 ribosome
biogenesis regulator homolog (Rrs1), RNA terminal phosphate
cyclase-like 1 (Rcl1), superkiller viralicidic activity 2-like 2
(Skiv2l2), and NOP2 nucleolar protein (Nop2) (Figure 1H). In
contrast, the expression of these genes was significantly lower
in PDL14-MEFs compared with that in PDL4-MEFs (Figure 1I).
The 47/45S pre-rRNA levels in PDL14-MEFs after 60 min in the
pulse-chase labeling experiment were higher, and mature 18S
and 28S rRNA levels were lower in PDL14-MEFs than those in
PDL4-MEFs (Figure 1J, lanes 3 and 9). These results indicate
that rRNA processing is delayed in PDL14-MEFs. A similar
cellular response was observed in WI-38 human lung fibroblasts
(Figures S1H–S1K), indicating that this phenomenon is not cell
type specific. Taken together, oncogenic-stress-induced accel-
eration of rRNA transcription and replicative-stress-induced
delay in rRNA processing led to increased nucleolar RNA content
and nucleolar size.
Acceleration of rRNA Transcription or Inhibition of rRNA
Processing Leads to Cellular Senescence
Recent studies have revealed that the nucleolus senses various
stresses and plays a coordinating role in activating p53 (Boulon
et al., 2010; Rubbi and Milner, 2003). We considered the model
that aberrant ribosome biogenesis; accelerated rRNA tran-
scription and delayed rRNA processing, may induce p53 activa-
tion and cellular senescence under oncogenic and replicative
stresses. However, many signals and genes related to telomere
dysfunction, DDR, and oxidative stress response have been
implicated in these processes (Campisi and d’Adda di Fagagna,
2007; Cichowski andHahn, 2008; de Lange, 2009; Kuilman et al.,
2010; Parrinello et al., 2003; Schramek et al., 2011), and their
effects cannot be excluded.
To evaluate our senescence induction model, we first exam-
ined the effect of accelerated rRNA transcription observed under
oncogenic stress on cellular senescence. We overexpressed the
RNA polymerase I transcription factor TIF-IA in MEFs to accel-
erate rRNA transcription. We confirmed that overexpressing
TIF-IA enhanced rRNA transcription and increased nucleolar
RNA content (Figures 2A and 2B). Overexpression of TIF-IA
also induced accumulation of p53 and its downstream target
p21 (Figure 2C). PUMA, a BH3-only protein essential for p53-
dependent apoptosis, was not induced by this treatmentll Reports 10, 1310–1323, March 3, 2015 ª2015 The Authors 1311
Figure 1. Acceleration of rRNA Transcription by Oncogenic HRasG12V and Defects in rRNA Processing by Replicative Stress Increases
Nucleolar RNA Content
(A–E, left, F, andH)Results usingMEFs transducedwith retrovirus-expressingHRasG12V, E2F1, orwith control (Ctrl) vector for 4 days (A,C–F, andH) or for 7 days (B).
(A–E, right, G, and I) Results using early-passage (PDL4) and late-passage (PDL14) MEFs.
(legend continued on next page)
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(Figure 2C). Overexpression of TIF-IA increased the protein level
of p16 (Figure 2C), the number of SA-b-gal-positive cells (Fig-
ure 2D), and enlarged nucleoli (Figure 2E), indicating the induc-
tion of cellular senescence. It is well recognized that the
senescence-associated secretory phenotype (SASP) is amarker
for senescent cells (Campisi, 2013; Rodier and Campisi, 2011;
Tchkonia et al., 2013). Therefore, we evaluated the expression
levels of SASP factors: Matrix metallopeptidase 1 (Mmp-1),
Matrix metallopeptidase 10 (Mmp-10), Plasminogen activator
inhibitor-1 (Pai-1), Leptin receptor (LeptinR), chemokine (c-x-c
motif) receptor 2 (Cxcr2), TIMP metallopeptidase inhibitor 1
(Timp1). Overexpression of TIF-IA increased the expression of
the SASP factors, except that of Mmp-1 (Figure 2F). Taken
together, these data show that oncogenic-stress-induced upre-
gulation of rRNA transcription causes aberrant ribosome biogen-
esis, resulting in the activation of p53 and cellular senescence.
Further, we depleted the rRNA-processing factors Dkc1, Rrp5,
and Rrs1, which play a distinct role in rRNAmaturation (Ge et al.,
2010; Lebaron et al., 2013; Mochizuki et al., 2004; Turner et al.,
2009; Zhang et al., 2007) and were downregulated in PDL14-
MEFs (Figure 1I), to investigatewhether delayed rRNAprocessing
activates p53 and cellular senescence during replicative stress.
Depletion of these genes inhibited rRNA processing (Figure 2G)
and increased nucleolar RNA content in MEFs and MCF-7 cells
(Figures 2H and S2A), which was similar to results observed in
PDL14-MEFs. Immunoblotting revealed that depletion of these
factors led to the accumulation of p53, p21, and p16 (Figures 2I
and S2B). In addition, the cells depleted of these factors also dis-
played a flattenedmorphology, elevated SA-b-gal activity, and an
enlarged nucleolus (Figures 2J, 2K, S2C, and S2D). Furthermore,
depletion of these factors increased the expression of SASP
factors, with an exception of depletion of Rrp5, which decreased
Pai-1 expression inMEFs (Figure 2L).Whenwedepleted theother
rRNA-processing factors, such as pescadillo ribosomal biogen-
esis factor 1 (PES1), WD repeat domain 3 (WDR3), BMS1 ribo-
some biogenesis factor (BMS1), and UTP6 small subunit
processome component (UTP6) in MCF-7 cells, we found that
all the cells accumulated p53, p21, and p16 (Figure S2E),
increased SA-b-gal activity (Figure S2F), and developed an
enlarged nucleolus (Figure S2G). These observations are most
consistent with the notion that aberrant ribosome biogenesis ac-
tivates p53, resulting in cellular senescence under replicative
stress.(A) Immunoblotting was performed using the indicated antibodies.
(B) Microscopy and SA-b-gal staining were performed. Scale bar, 60 mm.
(C) Immunofluorescence staining was performed using the indicated antibodies. U
(D) Northern blotting was performed using a probe specific to the rRNA ITS1 reg
control.
(E) Nucleolar RNAwas isolated from the purified nucleoli andwas quantified using
PDL4) was normalized to 1.0.
(F and G) Transcription of pre-rRNA was assessed by nuclear run-on assays, a
(qRT-PCR) (n = 3). pre-rRNA levels were normalized to cyclophilin mRNA levels.
(H and I) Expression of rRNA-processing factors was assessed by qRT-PCR (n =
mRNA levels.
(J) PDL4, PDL10, and PDL14 MEFs were examined by pulse-chase labeling. Cells
chased with cold methionine for 30 and 60 min. Sizes of the processing interm
normalized to total RNA. EtBr-stained gel is shown at the right as a loading cont
Error bars indicate SD; *p < 0.05; **p < 0.01; n.s., not significant. See also Figure
CeThep53-p21Pathway Is Involved inCellular Senescence
Induced by Accelerating rRNA Transcription or
Inhibiting rRNA Processing
Our results indicate that upregulation of rRNA transcription or in-
hibition of rRNA processing increased the level of p53 and its
downstream target p21 and induced cellular senescence (Fig-
ure 2). The question is whether p53 and/or p21 were involved
in the cellular senescence induced by accelerating rRNA tran-
scription or inhibiting rRNA processing.
To clarify this question, we overexpressed TIF-IA in MEFs and
depleted p53 and p21 (Figure 3A). Overexpression of TIF-IA
increased the number of SA-b-positive cells, which was counter-
acted by p53 or p21 depletion (Figure 3B). Next, we assessed
the contribution of p53 or p21 in inducing senescence in MEFs
depleted of the rRNA-processing factors, Dkc1, Rrp5, or Rrs1
(Figure 3C). As with the case of TIF-IA overexpression, the
increased number of SA-b-positive cells by the depletion of the
rRNA-processing factors was counteracted by p53 or p21
depletion (Figure 3D). Similar results were obtained when p53
was depleted from MCF-7 cells (Figure S3). Taken together,
the results show that the p53-p21 pathway plays a critical role
in cellular senescence induced by accelerating rRNA transcrip-
tion or inhibiting rRNA processing.
5S RNP Components, Including RPL11, RPL5, and 5S
rRNA, Are Required for Cellular Senescence
Ribosome-free RPL11 and RPL5 reportedly diffuse into the
nucleoplasm during ribotoxic stress where they inhibit MDM2
and promote the activation of p53 (Bhat et al., 2004; Dai and
Lu, 2004; Lohrum et al., 2003; Marechal et al., 1994; Zhang
et al., 2003). We observed aberrant ribosome biogenesis under
oncogenic and replicative stresses. Here we predicted that
RPL11 and RPL5 are involved in activating p53 and cellular
senescence under these stresses. Thus, we evaluated the quan-
tities of endogenous ribosome-free RP11 and RPL5 in MEFs by
isolating ribosomal (Ribo) and nonribosomal (Non Ribo) fractions
from unstressed and stressed cells. The obtained cell lysates
were subjected to sucrose gradient centrifugation followed
by immunoblotting with anti-RPL11 and anti-RPL5 antibodies
(Figure 4A). As a striking feature, we detected a marked increase
in the quantity of ribosome-free RPL11/RPL5 in HRasG12V-
expressing cells (Figure 4A, left) and in PDL14-MEFs (Figure 4A,
right). Similarly, co-immunoprecipitation experiments showedBF andMYBBP1A (MYBBP) were used as nucleolar markers. Scale bar, 10 mm.
ion. Ethidium bromide (EtBr)-stained gel is shown at the bottom as a loading
spectrophotometry (n = 3). Nucleolar RNA content of control cells (Ctrl vector or
nd pre-rRNA and cyclophilin signals were quantified by quantitative RT-PCR
3). rRNA-processing factor expression levels were normalized to cyclophilin
were labeled with 50 mCi/ml 3H-labeled methyl methionine for 30 min and were
ediates and mature RNA species are indicated on the left. Each sample was
rol.
S1.
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Figure 3. Acceleration of rRNA Transcription or Defects in rRNA Processing Induce p53-Dependent Cellular Senescence
(A) MEFs were transduced with retrovirus expressing TIF-IA or with Ctrl vector for 2 days before treatment with siCtrl, sip53#1, or sip21#1. Cell lysates were
prepared on day 5 after infection and analyzed by immunoblotting using the indicated antibodies.
(B) MEFs were transduced with retrovirus expressing TIF-IA or with Ctrl vector. These cells were treated with siCtrl, sip53#1, or sip21#1 on days 2 and 5 after
infection. Microscopy and SA-b-gal staining were performed on day 7 after infection. Scale bar, 60 mm.
(C)MEFswere treatedwith the indicated combinations of siRNA (siCtrl, sip53#1, sip21#1, siDkc1, siRrp5, siRrs1) on days 0 and 3. Cell lysates were prepared from
these cells on day 5 after the first transfection and were immunoblotted using indicated antibodies.
(D) MEFs were treated with the indicated combinations of siRNA (siCtrl, sip53#1, sip21#1, siDkc1, siRrp5, siRrs1) on days 0 and 3. Microscopy and SA-b-gal
staining were performed on day 6 after the first transfection. Scale bar, 60 mm.
See also Figure S3.that the oncogenic and replicative stresses reduced the
interaction between MDM2 and p53 (Figure 4B). In contrast,
the interaction between MDM2 and RPL11/RPL5 was enhanced
(Figure 4B). These results indicate that oncogenic and replicative
stresses increase the levels of ribosome-free RPL11 and RPL5,
which bind to and inhibit MDM2.
Oncogenic and replicative stresses increase the expression of
the nucleolar protein Arf (Bracken et al., 2007; Dimri et al., 2000;Figure 2. Acceleration of rRNA Transcription and Defects in rRNA Pro
(A–F) MEFs were transduced with retrovirus-expressing TIF-IA or with Ctrl vecto
(A) pre-rRNA transcription was assessed on day 4 after infection by nuclear run-
(n = 3). pre-rRNA levels were normalized to cyclophilin mRNA levels.
(B) Nucleolar RNA content was spectrophotometrically assessed on day 4 after
(C) Immunoblotting was performed using the indicated antibodies on day 4 after
(D) Microscopy and SA-b-gal staining were performed on day 7 after infection. S
(E) Immunofluorescence staining was performed using the indicated antibodies
(F) Expression of SASP factors was assessed on day 4 after infection by qRT-PC
levels.
(G–L) MEFs were treated with siRNA against Ctrl, Dkc1, Rrp5, or Rrs1.
(G) Northern blotting was performed at 60 hr after transfection using a probe sp
loading control.
(H) Nucleolar RNA content was spectrophotometrically assessed at 60 hr after tr
(I) Immunoblotting was performed using the indicated antibodies at 60 hr after tr
(J) Indicated siRNAs were treated on days 0 and 3. Microscopy and SA-b-gal sta
(K) Immunofluorescence staining was performed using indicated antibodies at 6
(L) Expression of SASP factors was assessed on day 5 after transfection by qRT-P
levels.
Error bars indicate SD; *p < 0.05; **p < 0.01. See also Figure S2.
CeSreeramaneni et al., 2005; Wei et al., 2001; Zindy et al., 1998),
which leads to the accumulation of p53 by binding to MDM2
(Kamijo et al., 1998; Pomerantz et al., 1998; Randle et al.,
2001; Zhang and Xiong, 1999). Immunoblotting showed that
Arf levels increased in the presence of oncogenic and replicative
stresses (Figure 4B, lanes 1, 2, 7, and 8). The co-immunoprecip-
itation experiments indicated an enhanced interaction between
Arf and MDM2 under these stresses (Figure 4B, lanes 5, 6, 11,cessing Triggers Cellular Senescence
r.
on assays, and pre-rRNA and cyclophilin signals were quantified by qRT-PCR
infection (n = 3). Nucleolar RNA content of Ctrl cells was normalized to 1.0.
infection.
cale bar, 60 mm.
on day 4 after infection. Scale bar, 10 mm.
R (n = 3). SASP factor expression levels were normalized to cyclophilin mRNA
ecific for the rRNA ITS1 region. EtBr-stained gel is shown at the bottom as a
ansfection (n = 3). Nucleolar RNA content of Ctrl cells was normalized to 1.0.
ansfection (upper panels) and on day 5 after transfection (lower panels).
ining were performed on day 6 after the first transfection. Scale bar, 60 mm.
0 hr after transfection. Scale bar, 10 mm.
CR (n = 3). SASP factor expression levels were normalized to cyclophilin mRNA
ll Reports 10, 1310–1323, March 3, 2015 ª2015 The Authors 1315
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and 12). These results suggest a connection between Arf and
the ribosomal proteins that activate p53 in response to onco-
genic and replicative stresses, which is consistent with reports
showing a functional connection between Arf and RPL11 (Dai
et al., 2012; Sloan et al., 2013a; Zhang et al., 2003).
Next, we assessed the contribution of RPL11 and RPL5 in p53
activation under oncogenic and replicative stress conditions.
RPL11 or RPL5 depletion suppressed the accumulation of
p53 and p21 induced by the oncogenic and replicative stresses
(Figures 4C, 4D, and S4D). The increased p16 level was also
compromised by RPL11 or RPL5 depletion (Figures 4C, 4D,
and S4D). Depleting RPL11 or RPL5 decreased the number of
SA-b-gal-positive cells under these stresses (Figures 4E, 4F,
and S4E). These data indicate that oncogenic and replicative
stresses induce the accumulation of RPL11 and RPL5 in the
ribosome-free fraction where they bind to MDM2, resulting in
the activation of p53 and cellular senescence.
RPL11 and RPL5 comprise 5S RNP together with 5S rRNA
(Zhang et al., 2007). Recent studies have revealed that 5S RNP
is essential for activating p53 in response to ribotoxic stresses
(Donati et al., 2013; Sloan et al., 2013a). We then examined
whether 5S rRNA, the other 5S RNP component, was required
to activate p53 under oncogenic and replicative stresses. The
depletion of TFIIIA, a cofactor specifically required for 5S rRNA
transcription (Shastry et al., 1984), effectively inhibited 5S
rRNA biogenesis (Figures S4A and S4B) without affecting tRNA
production (Figure S4C), which was consistent with a previous
report (Donati et al., 2013). We found that TFIIIA depletion abro-
gated the accumulation of p53, p21, and p16, aswell as the num-
ber of SA-b-gal-positive cells in HRasG12V- or E2F1-expressing
MEFs and PDL14-MEFs (Figures 4G, 4H, S4D, and S4E). Taken
together, any of the 5S RNP components, such as RPL11, RPL5,
and 5S rRNA, are necessary for oncogenic-stress- or replicative-
stress-induced activation of p53 and cellular senescence.
RPL11 Is Required for p53 Activation and Cellular
Senescence Caused by Perturbation of Ribosome
Biogenesis
We investigated whether experimental upregulation of rRNA
transcription or downregulation of rRNA processing, which
were observed under oncogenic or replicative stress, induce
p53 activation and cellular senescence in a 5S RNP-dependent
manner. We first tested whether the 5S RNP component is
required for p53 activation and senescence induced by aberrantFigure 4. 5S RNP Components Induce p53 Activation and Cellular Sen
(A) MEFs were transduced with retrovirus-expressing HRasG12V or with Ctrl vect
sucrose gradient centrifugation and immunoblotted using indicated antibodies on
PDL14 MEFs (right); Fr. #, fraction number.
(B) MEFs were transduced with retrovirus-expressing HRasG12V or with Ctrl vec
after infection and were immunoblotted with the indicated antibodies. Loading re
experiment was performed using PDL4 and PDL14 MEFs (right).
(C, D, and G) (left) MEFs were transduced with retrovirus-expressing HRasG12V
lysates were prepared on day 5 after infection and analyzed by immunoblotting u
indicated siRNAs every 3 days, and cell lysates from PDL4 and/or PDL14 MEFs
(E, F, and H) (left) MEFs were transduced with retrovirus-expressing HRasG12V o
cells were treated with the indicated siRNAs on days 2 and 5 after infection. SA-
Early-passage MEFs were treated with the indicated siRNAs every 3 days, and SA
See also Figure S4.
Ceupregulation of rRNA transcription. Thus, we depleted RPL11
in TIF-IA-overexpressing cells. We found that RPL11 depletion
suppressed the accumulation of p53, p21, and p16, and the
number of SA-b-gal-positive cells induced by TIF-IA overexpres-
sion (Figures 5A and 5B). Next, we tested whether 5S RNP is
required for p53 activation and cellular senescence induced by
downregulating rRNA processing. We depleted RPL11 in the
presence of small interfering RNAs (siRNAs) specific for DKC1,
RRP5, and RRS1, any of which induced p53 accumulation,
p21 induction, p16 induction, and cellular senescence (Figures
2I, 2J, S2B, and S2C). We found that RPL11 depletion abrogated
these events (Figures 5C and 5D). Thus, overexpressing TIF-IA
or depleting the rRNA-processing factors lead to phenotypes
similar to those observed under oncogenic or replicative stress
via 5S RNP.
Taken together, our results (Figures 1, 2, 3, 4, and 5) indicated
that oncogenic or replicative stresses increase nucleolar size,
trigger p53 accumulation, p21 induction, and cellular senes-
cence by perturbing ribosome biogenesis, such as upregulating
rRNA transcription or inhibiting rRNA processing, respectively.
Our results also show that perturbing ribosome biogenesis
induces 5S RNP-mediated p53 activation under oncogenic or
replicative stresses.
Arf Downregulates rRNA-Processing Factors under
Replicative Senescence
Next, we uncovered the molecular basis for aberrant ribosome
biogenesis in senescent cells. Although oncogenic HRasG12V
or E2F1 enhances rRNA transcription via extracellular signal-
regulated kinase (ERK) (Zhao et al., 2003), it remains unclear
how the expression of rRNA-processing factors is suppressed
under replicative stress. c-Myc upregulates expression of
the rRNA-processing factors such as Dkc1, Rrp5, and Rrs1
(Schlosser et al., 2003; van Riggelen et al., 2010). Arf binds
and inhibits c-Myc transcriptional activity, independently of
p53 (Datta et al., 2004; Qi et al., 2004). Hence, Arf may block
rRNA processing by repressing c-Myc. Consistent with this hy-
pothesis, Arf depletion restored the levels of rRNA-processing
factors that were downregulated in senescent MEFs (Figure 6A).
In contrast, the depletion of p53 or p21 did not markedly influ-
ence levels of the rRNA-processing factors (Figure S5), sug-
gesting that Arf regulates expression of rRNA-processing factors
independently of p53. Arf depletion also counteracted the
increase in nucleolar RNA content following replicative stressescence under Oncogenic and Replicative Stresses
or. Ribosomal (Ribo) and nonribosomal (Non Ribo) fractions were isolated by
day 4 after infection (left). The same experiment was performed using PDL4 and
tor. Cell lysates were immunoprecipitated with anti-MDM2 antibody on day 4
presents 30% of the total lysate used for immunoprecipitation (left). The same
or with Ctrl vector for 2 days before treatment with the indicated siRNAs. Cell
sing the indicated antibodies. (right) Early-passage MEFs were treated with the
were analyzed by immunoblotting.
r with Ctrl vector for 2 days before treatment with the indicated siRNAs. These
b-gal staining was performed on day 7 after infection. Scale bar, 60 mm. (right)
-b-gal staining was performed with PDL4 and PDL14 MEFs. Scale bar, 60 mm.
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Figure 5. Accelerated rRNA Transcription or Inhibited rRNA Processing Induces p53 Activation and Cellular Senescence via RPL11
(A) MEFs were transduced with retrovirus expressing TIF-IA or with Ctrl vector for 2 days before treatment with siCtrl or siRPL11. Cell lysates were prepared on
day 5 after infection and analyzed by immunoblotting using the indicated antibodies.
(B) MEFs were transduced with retrovirus expressing TIF-IA or with Ctrl vector. These cells were treated with siCtrl or siRPL11 on days 2 and 5 after infection.
Microscopy and SA-b-gal staining were performed on day 7 after infection. Scale bar, 60 mm.
(C) MCF-7 cells were transfected with the indicated combinations of siRNA on day 0 (for upper panels) or on days 0 and 3 (for lower panels). Cell lysates were
prepared from these cells andwere immunoblotted using the indicated antibodies at 60 hr after transfection (upper panels) and on day 5 after the first transfection
(lower panels).
(D) MCF-7 cells were treated with the indicated siRNAs on days 0 and 3. Microscopy and SA-b-gal staining were performed on day 6 after the first transfection.
Scale bar, 60 mm.(Figure 6B). These results suggest that Arf inhibits rRNA pro-
cessing by downregulating the rRNA-processing factors under
replicative stress. Furthermore, Arf depletion suppressed p53
accumulation (Figure 6C), p21 induction (Figure 6C), SA-b-gal
activation (Figure 6D), and nucleolar enlargement (Figure 6E),
which is in agreement with our data, which suggest that downre-
gulation of the rRNA-processing factors led to 5S RNP-mediated
p53 activation and cellular senescence (Figures 1, 2, 3, 4, and 5).
Direct binding of Arf to MDM2 prevents ubiquitin-mediated
degradation of p53 and promotes cellular senescence (Kamijo
et al., 1998; Pomerantz et al., 1998; Randle et al., 2001; Zhang
andXiong, 1999).Consistentwith these reports,wedemonstrated
that replicative stress enhanced the interaction between Arf and
MDM2 (Figure 4B, right). Along with this pathway in which Arf
directly inhibitsMDM2, our results indicate that Arf-mediated inhi-
bition of rRNA processing may lead to p53 activation and cellular
senescence via 5S RNP. Thus, it appears that both pathways
cooperatively activate p53, leading to replicative senescence.
Exogenous Expression of rRNA-Processing Factors
Extends the Replicative Lifespan of MEFs
Finally, we determined whether exogenous expression of the
rRNA-processing factors abrogates replicative senescence,1318 Cell Reports 10, 1310–1323, March 3, 2015 ª2015 The Authorsbecause decreased expression of the rRNA-processing genes
delayed rRNA processing, increased nucleolar RNA content,
and resulted in replicative senescence. We exogenously ex-
pressed Dkc1, Rrp5, and Rcl1, whose expression decreased in
PDL14-MEFs, and examined the nucleolar content. Exogenous
expression of Dkc1 or Rrp5 suppressed the increase in nucleolar
RNAcontent, indicating recovery of rRNAprocessing (Figure 7A).
In contrast, Rcl1 overexpression modestly affected nucleolar
RNA content of PDL14-MEFs (Figure 7A). Under these condi-
tions, immunoblotting showed that exogenous expression of
Dkc1 or Rrp5 inhibited the accumulation of p53, p21, and p16
in PDL14-MEFs (Figure 7B). The effect of Rcl1 overexpression
was not so evident (Figure 7B). In addition, exogenous expres-
sion of Dkc1 or Rrp5 extended the replicative lifespan of MEFs
(Figure 7C). Replicative-stress-enhanced SA-b-gal activity
and nucleolar enlargement were also abrogated by exogenous
expression of Dkc1 and Rrp5 (Figures 7D and 7E). In contrast,
the effect of exogenous expression of Rcl1 on replicative lifespan
(Figure 7C), SA-b-gal activity (Figure 7D), and nucleolar size (Fig-
ure 7E) was not as apparent as that of Dkc1 and Rrp5, indicating
a correlation between restored nucleolar RNA content and
extending replicative lifespan capacity. The effect of exogenous
expression of Dkc1 and Rrp5 on SASP was less evident;
Figure 6. Arf Suppresses Expression of rRNA-Processing Factors under Replicative Stress
(A–E) Early-passage MEFs were treated with siCtrl, siArf #1, or siArf#2 every 3 days.
(A) rRNA-processing factor expression was assessed by qRT-PCR in PDL4 and PDL14 MEFs (n = 3). rRNA-processing factor expression levels were normalized
to cyclophilin mRNA levels.
(B) Nucleolar RNA content was spectrophotometrically quantified in PDL4 and PDL14 MEFs (n = 3). Nucleolar RNA content of PDL4-Ctrl cells was
normalized to 1.0.
(C) Cell lysates from PDL14 MEFs were immunoblotted using the indicated antibodies.
(D) SA-b-gal staining was performed with PDL4 and PDL14 MEFs. Scale bar, 60 mm.
(E) Immunofluorescence staining was performed with PDL14 MEFs using the indicated antibodies. Scale bar, 10 mm.
Error bars indicate SD; *p < 0.05; **p < 0.01. See also Figure S5.however, increased expression of SASP factors in old MEFs
partially decreased by exogenous expression of the rRNA-pro-
cessing factors (Figure 7F). Taken together, these data strongly
support our model that suggests that impaired rRNA processing
induces replicative senescence.
DISCUSSION
Normal somatic cells can undergo permanent growth arrest after
a finite number of cell divisions (replicative stress) or activation of
oncogenes (oncogenic stress), accompanied by p53 activation.
In this study, we showed that oncogenic stress accelerated
rRNA transcription, whereas replicative stress impaired rRNACeprocessing, both of which triggered 5S RNP-mediated p53
activation and cellular senescence (Figure 7G).
We also found that expression of the rRNA-processing factors
decreased because of replicative stress, which impaired rRNA
processing and limited the number of cell divisions. The replica-
tive lifespan of MEFs was extended by exogenous expression of
the rRNA-processing factors.
Defects in rRNA Processing Induce p53 Activation and
Cellular Senescence under Replicative Stress
5S RNP components activate p53 when ribosome biogenesis is
blocked by siRNA-mediated depletion of rRNA transcription
or -processing factors (Donati et al., 2011, 2013; Ho¨lzel et al.,ll Reports 10, 1310–1323, March 3, 2015 ª2015 The Authors 1319
Figure 7. Exogenous Expression of Certain rRNA-Processing Factors Restores Nucleolar RNAContent and Extends theReplicative Lifespan
of MEFs
(A) Early-passage MEFs were transfected with the indicated plasmids. Nucleolar RNA was isolated from the purified nucleoli on days 2 and 14 after transfection
and quantified by spectrophotometry (n = 3). Nucleolar RNA content of the day 2-Ctrl cells was normalized to 1.0.
(B) Early-passage MEFs were transfected with the indicated plasmids and immunoblotted using the indicated antibodies on day 14 after transfection.
(C) Growth curves of MEFs transfected with the indicated plasmids. Day 2 is the second day after selection.
(D) Early-passageMEFswere transfected with the indicated plasmids and analyzed using SA-b-gal staining on days 2 and 14 after transfection. Scale bar, 60 mm.
(E) Early-passageMEFswere transfectedwith the indicated plasmids and analyzed by immunofluorescence staining using the indicated antibodies on days 2 and
14 after transfection. Scale bar, 10 mm.
(F) Early-passage MEFs were transfected with the indicated plasmids. Expression of SASP factors was assessed by qRT-PCR (n = 3) on days 2 and 14 after
transfection. SASP factor expression levels were normalized to cyclophilin mRNA levels.
(G) Model of senescence induction via 5S RNP under oncogenic or replicative stress. See text for details.
Error bars indicate SD; *p < 0.05; **p < 0.01; n.s., not significant.2010). Physiological stresses, such as gamma-irradiation (Bhat
et al., 2004), nutrient restriction (Grummt et al., 1976; Kumazawa
et al., 2011), or hypoxia (Mekhail et al., 2006), inhibit rRNA tran-1320 Cell Reports 10, 1310–1323, March 3, 2015 ª2015 The Authorsscription (Boulon et al., 2010; Rubbi and Milner, 2003), whereas
factors that inhibit rRNA processing have not been identified.
Here, we show that replicative stress inhibited rRNA processing
and caused cellular senescence. Namely, expression of the
rRNA-processing factors decreased in late-passage PDL14-
MEFs, which caused defects in rRNA processing (Figures 1I
and 1J). These cells displayed enlarged and flattened shapes,
enlarged nucleoli, and accumulated p53 and p16, which are
typical characteristics of senescent cells (Figures 1A–1C). These
phenotypes were rescued by exogenously expressing certain
rRNA-processing factors (Figure 7), demonstrating the physio-
logical significance of rRNA-processing defects.
Our results showed that exogenous expression of Dkc1 and
Rrp5 rescued the processing defects and attenuated cellular
senescence. However, it was odd that exogenous expression
of the single rRNA-processing gene rescued the processing de-
fects because rRNA processing in eukaryotic cells requires a
large number of proteins (Tafforeau et al., 2013), some of which
decreased in senescent cells (Figure 1I). Rrp5 is reportedly
involved in pre-rRNA cleavage at sites A0–A2 in the 18S rRNA
synthetic pathway and A3 cleavage in the 5.8S/25S rRNA syn-
thetic pathway (Lebaron et al., 2013; Turner et al., 2009). Dkc1
also functions in multiple rRNA-processing steps by regulating
pseudouridine synthesis (Ge et al., 2010; Mochizuki et al.,
2004). In contrast, Rcl1, whose expression partially rescued pro-
cessing defects and cellular senescence, is mainly required for
18S rRNA biogenesis (Horn et al., 2011; Sloan et al., 2013b;
Turner et al., 2009). Based on these observations, we speculate
that Dkc1 and Rrp5 are comprehensively involved in processing;
therefore, their exogenous expression may upregulate rRNA
processing. Expression of Dkc1 or Rrp5, which restored nucle-
olar RNA content, extended replicative lifespan (Figures 7A
and 7C). The effect of Rcl1 overexpression on nucleolar RNA
content and replicative lifespan was not as evident (Figures 7A
and 7C). These results suggest that rRNA-processing defects
are strongly implicated in the induction of senescence under
replicative stress.
Arf Inhibits rRNA Processing in Response to Replicative
Stress
We found that Arf depletion restored the decreased expression of
rRNA-processing factorsunder replicativestress.Arf accumulates
in late-passage cells (Figure 4B, lanes 7 and 8), which is consistent
with previous reports (Dimri et al., 2000; Zindy et al., 1998), and
inhibits c-Myc transcriptional activity (Datta et al., 2004; Qi et al.,
2004). c-Myc transcriptionally upregulates ribosomal components
(Schlosser et al., 2003; van Riggelen et al., 2010). These results
suggest that restoring rRNA processing by Arf depletion is due
to cancelation of the Arf inhibitory effects on c-Myc. Along with
thedirect inhibitionofMDM2byArf (Kamijoet al., 1998;Pomerantz
etal., 1998;Randleetal., 2001;ZhangandXiong,1999),our results
indicate thatArf-mediateddefects in rRNAprocessingmay lead to
p53 activation and cellular senescence via 5S RNP (Figure 7G).
This result is consistent with previous reports demonstrating a
functional connection between RPL11 and Arf (Dai et al., 2012;
Sloan et al., 2013a; Zhang et al., 2003).
Nucleolar-5S RNP-p53 Signaling during Senescence
Thesenescence responsehinders tumor formationbypreventing
proliferation of pre-malignant cells. However, recent studies have
revealed that senescent cells are associated with age-relatedCedysfunction and tumorigenesis through the inflammatory
response. Therefore, it is important to understand senescence
signaling. Many signals and genes related to telomere dysfunc-
tion, DDR, andoxidative stress response activate p53 and induce
cellular senescence (Campisi and d’Adda di Fagagna, 2007; Ci-
chowski and Hahn, 2008; de Lange, 2009; Kuilman et al., 2010;
Parrinello et al., 2003; Schramek et al., 2011). It is alsowell known
that the nucleolus senses various stresses and is a central hub for
coordinating the stress response and transmitting signals to
regulate p53 (Boulon et al., 2010; Rubbi and Milner, 2003).
In this study, we showed the mechanisms of how oncogenic
or replicative stress triggers 5S RNP-mediated p53 activation
and cellular senescence. In addition, we observed that hydrogen
peroxide (H2O2) inducedRPL11- andRPL5-mediated p53 activa-
tion (Figure S6A) and cellular senescence (Figure S6B). The 5S
RNPcomponentspromotedp53activation inall cases.Therefore,
it appears that nucleolar surveillance signaling is required for a
broad range of senescence induction activities. Understanding
these processes will provide necessary insights into senescence
and could contribute to new treatments for age-relateddisorders.
EXPERIMENTAL PROCEDURES
Cell Culture
MCF-7 human breast cancer cells were maintained in DMEM containing
1,000 mg/l glucose supplemented with 10% fetal bovine serum (FBS), 100
units/ml penicillin, and 100 mg/ml streptomycin. MEFs and WI-38 cells were
cultured in DMEM containing 4,500 mg/l glucose with 10% FBS, 100 units/
ml penicillin, and 100 mg/ml streptomycin. The cells were cultured in 5%
CO2 and 20% oxygen conditions.
Retroviral Infection
MEFs, WI-38, and MCF-7 cells were transiently infected with the pBabe-
HRasG12V, pBabe-TIF-IA, and the corresponding control vector using the
293GP cell line. Eighty percent confluent 293GP cells were transfected, using
the Polyethylenimine MAX (Polysciences), with HRasG12V-expressing vector,
TIF-IA-expressing vector, or the GFP vector alone, and the obtained replica-
tion-incompetent retroviruses were used for the transduction of MEFs,
WI-38, and MCF-7 cells. The next day, after infection, the cells were selected
with the appropriate antibiotic for a day and collected at indicated times.
Nucleoli Purification and Quantitative Determination of Nucleolar
RNA Content
Nucleoli were isolated from 63 106 MEFs or 1.23 107 MCF-7 cells in high pu-
rify by density gradient fractionation as previously described (Andersen et al.,
2005). Total nucleolar RNA was prepared from the isolated nucleoli and quan-
tified by spectrometry. Statistical analysis was performed by Student’s t test.
Ribosomal and Nonribosomal Fractionation
MEFs were lysed with lysis buffer (10mMNaCl, 10mMMgCl2, 10mM Tris-HCl
[pH 7.5], 1% Triton X-100, 1% sodium deoxycholate, 36 U/ml RNase inhibitor,
and 1 mM DTT) and layered onto a 8%–48% sucrose gradient containing
30 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 10 mM MgCl2 and centrifuged
with a Beckman SW41 rotor for 240 min at 23,000 rpm. Fractions were
collected from the top of the gradient, and ribosomal and nonribosomal frac-
tions were determined using 18S/28S rRNA as an indicator.
See Supplemental Experimental Procedures for more information.
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